Characterization of cloned human cholecystokinin-B receptor as a gastrin receptor

[1]  L. F. Kolakowski,et al.  The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. , 1993, The Journal of biological chemistry.

[2]  G. Woodruff,et al.  [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa. , 1993, Molecular pharmacology.

[3]  A. Nishida.  Pharmacological profile of YM022, a potent and selective gastrin/cholecystokinin-B receptor antagonist , 1993 .

[4]  S. Wank,et al.  Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. , 1992, Biochemical and biophysical research communications.

[5]  C. Spraggs,et al.  Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum , 1992, British journal of pharmacology.

[6]  I. Nishimoto,et al.  Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. , 1992, The Journal of biological chemistry.

[7]  L. F. Kolakowski,et al.  Expression cloning and characterization of the canine parietal cell gastrin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Gylfe,et al.  Effects of gastrin on cytosolic free Ca2+ in individual, acid-secreting rat parietal cells. , 1992, Biochemical and biophysical research communications.

[9]  T. Gusdinar,et al.  "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa--I. Characterization by means of agonists. , 1991, Biochemical pharmacology.

[10]  T. Gusdinar,et al.  "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260). , 1991, Biochemical pharmacology.

[11]  T. Gusdinar,et al.  Biphasic kinetics of inositol 1,4,5‐trisphosphate accumulation, in gastrin‐stimulated parietal cells Effects of pertussis toxin and extracellular calcium , 1991, FEBS letters.

[12]  J. Bali,et al.  Involvement of a pertussis toxin-sensitive G protein in the action of gastrin on gastric parietal cells. , 1990, Biochimica et biophysica acta.

[13]  F. Sundler,et al.  Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. , 1990, Gastroenterology.

[14]  B. Costall,et al.  Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Bock,et al.  Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. , 1989, Molecular pharmacology.

[16]  R. Chang,et al.  A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. , 1989, European journal of pharmacology.

[17]  R. Chang,et al.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Paul R. McHugh,et al.  Two brain cholecystokinin receptors: implications for behavioral actions , 1986, Brain Research.

[19]  S. Snyder,et al.  Distinct cholecystokinin receptors in brain and pancreas. , 1980, Proceedings of the National Academy of Sciences of the United States of America.